ADC Therapeutics S.A. (ADCT)

Market Closed

17 Jul, 20:00

NYSE

1. 35

162.8M Market Cap

- P/E Ratio

- Div Yield

1.33M Volume

-2.35 Eps

$ 1.35

Previous Close

Investors:

+10

Add Transaction

Day Range

1.31 1.46

Year Range

0.78 4.98

Want to track ADCT and more in your Portfolio? 🎯

Get Started For Free

ADCT Stock Plunges on Safety Concerns Despite Positive Lymphoma Data

ADC Therapeutics stock plunges 53% after-hours as investors focus on safety concerns in a phase III DLBCL study of Zynlonta, despite meeting its primary efficacy goal.

Zacks | 1 month ago

ADC Therapeutics SA (ADCT) Discusses Phase III LOTIS-5 Trial Results and Next Steps in DLBCL Transcript

Seekingalpha | 1 month ago

ADC Therapeutics SA (ADCT) Q1 2026 Earnings Call Transcript

Seekingalpha | 2 months ago

ADC Therapeutics SA (ADCT) Reports Q1 Loss, Beats Revenue Estimates

ADC Therapeutics SA (ADCT) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to a loss of $0.36 per share a year ago.

Zacks | 2 months ago

Are Medical Stocks Lagging ADC Therapeutics (ADCT) This Year?

Here is how ADC Therapeutics SA (ADCT) and Bioventus (BVS) have performed compared to their sector so far this year.

Zacks | 2 months ago

Is ADC Therapeutics (ADCT) Stock Outpacing Its Medical Peers This Year?

Here is how ADC Therapeutics SA (ADCT) and Biogen Inc. (BIIB) have performed compared to their sector so far this year.

Zacks | 3 months ago

ADC Therapeutics SA (ADCT) Discusses ZYNLONTA Strategy, Clinical Progress, and Sales Growth Outlook Transcript

Seekingalpha | 3 months ago

Is ADC Therapeutics (ADCT) Outperforming Other Medical Stocks This Year?

Here is how ADC Therapeutics SA (ADCT) and ALX Oncology Holdings Inc. (ALXO) have performed compared to their sector so far this year.

Zacks | 4 months ago

ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue Estimates

ADC Therapeutics SA (ADCT) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to a loss of $0.29 per share a year ago.

Zacks | 4 months ago

Has ADC Therapeutics (ADCT) Outpaced Other Medical Stocks This Year?

Here is how ADC Therapeutics SA (ADCT) and Assertio (ASRT) have performed compared to their sector so far this year.

Zacks | 5 months ago

ADC Therapeutics SA (ADCT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Seekingalpha | 6 months ago

Are Medical Stocks Lagging ADC Therapeutics (ADCT) This Year?

Here is how ADC Therapeutics SA (ADCT) and Agenus (AGEN) have performed compared to their sector so far this year.

Zacks | 6 months ago

Blog Affiliate Program About Terms Privacy Help Contact Us